David P Crabb
Overview
Explore the profile of David P Crabb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
2812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montesano G, Rabiolo A, Garway-Heath D, Fu D, Gazzard G, Ometto G, et al.
Ophthalmol Glaucoma
. 2025 Mar;
PMID: 40089210
Purpose: To test the association between use of calcium channel blocker (CCB) medications and the rate of visual field (VF) progression in a large cohort of patients from five glaucoma...
2.
Terheyden J, Dunbar H, Schmitz-Valckenberg S, Behning C, Martinho C, Luhmann U, et al.
Eye (Lond)
. 2025 Feb;
PMID: 39910281
For the conduct of future interventional age-related macular degeneration (AMD) trials, the availability of clinical study endpoints is key. However, no endpoints have been accepted by regulators for evaluation of...
3.
Terheyden J, Holz F, Behning C, Dunbar H, Schmitz-Valckenberg S, Tufail A, et al.
Ophthalmologica
. 2025 Feb;
:1-11.
PMID: 39900013
Introduction: There is an unmet medical need for therapies in intermediate age-related macular degeneration (iAMD). The prospective European multicenter cohort study MACUSTAR validates structural, functional, and patient-reported iAMD endpoints for...
4.
Montesano G, Rabiolo A, Ometto G, Crabb D, Garway-Heath D
Invest Ophthalmol Vis Sci
. 2025 Jan;
66(1):32.
PMID: 39808119
Purpose: To investigate the effect of average intraocular pressure (IOP) on the true rate of glaucoma progression (RoP) in the United Kingdom Glaucoma Treatment Study (UKGTS). Methods: UKGTS participants were...
5.
Montesano G, Crabb D, Wright D, Rabiolo A, Ometto G, Garway-Heath D
Transl Vis Sci Technol
. 2024 Dec;
13(12):20.
PMID: 39671226
No abstract available.
6.
Wright D, Azuara-Blanco A, Cardwell C, Montesano G, Crabb D, Gazzard G, et al.
Ophthalmol Glaucoma
. 2024 Nov;
PMID: 39505150
Objective: To validate and update the Ocular Hypertension Treatment Study-European Glaucoma Prevention Study (OHTS-EGPS) model predicting risk of conversion from ocular hypertension (OHT) to glaucoma using electronic medical records (EMR)....
7.
Wu H, Hernandez R, Crabb D, Gazzard G, Harper R, King A, et al.
BMJ Open Ophthalmol
. 2024 Oct;
9(1.
PMID: 39419584
Background/aims: To elicit the preferences and calculate the willingness to pay (WTP) of patients with ocular hypertension (OHT) for eye monitoring services in the UK. Methods: Patients with OHT aged...
8.
Tan J, Yohannan J, Ramulu P, Kalloniatis M, Crabb D, Crowston J, et al.
Surv Ophthalmol
. 2024 Sep;
70(1):141-152.
PMID: 39349186
The Swedish Interactive Thresholding Algorithm (SITA) is the main measurement acquisition algorithm used on the Humphrey Field Analyser, the most commonly used instrument for visual field (VF) assessment worldwide. We...
9.
Wu H, Gazzard G, King A, Morgan J, Wright D, Crabb D, et al.
BMJ Open Ophthalmol
. 2024 Aug;
9(1).
PMID: 39209325
Background/aims: To assess the cost-effectiveness of making treatment decisions for patients with ocular hypertension (OHT) based on a risk prediction (RP) tool in the United Kingdom. Methods: A discrete event...
10.
Reddingius P, Kelly S, Ometto G, Garway-Heath D, Crabb D
Am J Ophthalmol
. 2024 Aug;
269:346-354.
PMID: 39209207
Purpose: Evidence to support the hypothesis that visual field (VF) status can improve after initiation of intraocular pressure (IOP) reducing treatment is controversial. We take advantage of participant eligibility data...